Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
514383, 546271, 548257, 548259, 548260, 548261, A61K 3144, A61K 3141, C07D40114, C07D40102
(1H-azol-1-ylmethyl)substituted benzotriazole derivatives, compositions containing the same, and methods of treating estrogen dependent disorders.
patent: 2943017 (1960-06-01), Sasse
patent: 4410539 (1983-10-01), Cross et al.
patent: 4602025 (1986-07-01), Hirsch et al.
patent: 4609666 (1986-09-01), Hirsch et al.
patent: 4652579 (1987-03-01), Holmwood
patent: 4804765 (1989-02-01), Acher et al.
patent: 4826862 (1989-02-01), Raeymaekers et al.
patent: 4859684 (1989-08-01), Raeymaekers et al.
Mason et al, Biochem. Pharmacol., vol. 34, No. 7, pp. 1087-1092 (1985).
Freyne Eddy J. E.
Raeymaekers Alfons H. M.
Van Gelder Josephu L. H.
Venet Marc G.
Janssen Pharmaceutica N.V.
Metz Charles J.
Rozycki Andrew G.
Sutto Anton H.
(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and p does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1267903